×
About 5,013 results

ALLMedicine™ Hyperbilirubinemia Center

Research & Reviews  2,475 results

Rebound Bilirubin Levels after Phototherapy in Neonates with Hyperbilirubinemia.
https://www.ncbi.nlm.nih.gov/pubmed/33118790
American Family Physician; Gordon P, Aldulaimi S et. al.

Oct 29th, 2020 - Rebound Bilirubin Levels after Phototherapy in Neonates with Hyperbilirubinemia.|2020|Gordon P,Aldulaimi S,Howe CL,|

Improving Evaluation and Treatment of Hyperbilirubinemia in Late Preterm Infants.
https://doi.org/10.1097/JPN.0000000000000523
The Journal of Perinatal & Neonatal Nursing; Brown SA, Waldrop J et. al.

Oct 20th, 2020 - Late preterm (LPT) infants are at an increased risk for hyperbilirubinemia. Accurate identification and early treatment are needed for optimal health outcomes. In a newborn nursery at an academic medical center, bilirubin levels were drawn at 24 h...

Effect of head covering on phototherapy induced hypocalcemia in term neonates with hype...
https://doi.org/10.3233/NPM-200442
Journal of Neonatal-perinatal Medicine; Asghar I, Khan IA et. al.

Oct 19th, 2020 - Phototherapy is the primary treatment for hyperbilirubinemia in neonates. Hypocalcemia is a lesser known but potential detrimental effect of phototherapy. It has been hypothesized that phototherapy inhibits pineal secretion of melatonin, which blo...

Predictability of transcutaneous bilirubinometry in late preterm and term infants at ri...
https://doi.org/10.3233/NPM-200486
Journal of Neonatal-perinatal Medicine; Dianova E, Fogel J et. al.

Oct 19th, 2020 - The aim was to assess the predictability of transcutaneous bilirubinometry in late preterm and term neonates at risk for pathological hyperbilirubinemia, and to identify the neonatal population in which transcutaneous bilirubin most accurately pre...

"Fenofibrate as an adjuvant to phototherapy in pathological unconjugated hyperbilirubin...
https://doi.org/10.1038/s41372-020-00861-2
Journal of Perinatology : Official Journal of the California Perinatal Association; Awad MH, Amer S et. al.

Oct 18th, 2020 - Despite widespread phototherapy usage, many new-born infants remain in need of other invasive lines of therapy, such as intravenous immunoglobulins and exchange transfusions. Assessment of the efficacy and the safety of adding fenofibrate to photo...

see more →

Guidelines  7 results

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Ata...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785051
Clinical Pharmacology and Therapeutics; Gammal RS, Court MH et. al.

Sep 29th, 2015 - The antiretroviral protease inhibitor atazanavir inhibits hepatic uridine diphosphate glucuronosyltransferase (UGT) 1A1, thereby preventing the glucuronidation and elimination of bilirubin. Resultant indirect hyperbilirubinemia with jaundice can c...

Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or ...
https://doi.org/10.1542/peds.2011-1494
Pediatrics Bhutani VK, et. al.

Sep 28th, 2011 - To standardize the use of phototherapy consistent with the American Academy of Pediatrics clinical practice guideline for the management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Relevant literature was reviewed. P...

Screening of infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy...
https://www.ncbi.nlm.nih.gov/pubmed/20704172
American Family Physician;

Aug 13th, 2010 - Screening of infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy: recommendation statement.|2010| ,|blood,diagnosis,prevention & control,

Universal screening for hyperbilirubinemia.
https://doi.org/10.1111/j.1751-486X.2010.01516.x
Nursing for Women's Health;

Feb 8th, 2010 - Universal screening for hyperbilirubinemia.|2010||blood,blood,diagnosis,standards,

Universal screening for hyperbilirubinemia.
https://doi.org/10.1111/j.1552-6909.2009.01098.x
Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN;

Dec 30th, 2009 - Universal screening for hyperbilirubinemia.|2009| ,|diagnosis,etiology,prevention & control,methods,standards,methods,nursing,standards,

see more →

Drugs  4 results see all →

Clinicaltrials.gov  2,495 results

Rebound Bilirubin Levels after Phototherapy in Neonates with Hyperbilirubinemia.
https://www.ncbi.nlm.nih.gov/pubmed/33118790
American Family Physician; Gordon P, Aldulaimi S et. al.

Oct 29th, 2020 - Rebound Bilirubin Levels after Phototherapy in Neonates with Hyperbilirubinemia.|2020|Gordon P,Aldulaimi S,Howe CL,|

Improving Evaluation and Treatment of Hyperbilirubinemia in Late Preterm Infants.
https://doi.org/10.1097/JPN.0000000000000523
The Journal of Perinatal & Neonatal Nursing; Brown SA, Waldrop J et. al.

Oct 20th, 2020 - Late preterm (LPT) infants are at an increased risk for hyperbilirubinemia. Accurate identification and early treatment are needed for optimal health outcomes. In a newborn nursery at an academic medical center, bilirubin levels were drawn at 24 h...

Effect of head covering on phototherapy induced hypocalcemia in term neonates with hype...
https://doi.org/10.3233/NPM-200442
Journal of Neonatal-perinatal Medicine; Asghar I, Khan IA et. al.

Oct 19th, 2020 - Phototherapy is the primary treatment for hyperbilirubinemia in neonates. Hypocalcemia is a lesser known but potential detrimental effect of phototherapy. It has been hypothesized that phototherapy inhibits pineal secretion of melatonin, which blo...

Predictability of transcutaneous bilirubinometry in late preterm and term infants at ri...
https://doi.org/10.3233/NPM-200486
Journal of Neonatal-perinatal Medicine; Dianova E, Fogel J et. al.

Oct 19th, 2020 - The aim was to assess the predictability of transcutaneous bilirubinometry in late preterm and term neonates at risk for pathological hyperbilirubinemia, and to identify the neonatal population in which transcutaneous bilirubin most accurately pre...

"Fenofibrate as an adjuvant to phototherapy in pathological unconjugated hyperbilirubin...
https://doi.org/10.1038/s41372-020-00861-2
Journal of Perinatology : Official Journal of the California Perinatal Association; Awad MH, Amer S et. al.

Oct 18th, 2020 - Despite widespread phototherapy usage, many new-born infants remain in need of other invasive lines of therapy, such as intravenous immunoglobulins and exchange transfusions. Assessment of the efficacy and the safety of adding fenofibrate to photo...

see more →

News  31 results

Malpractice Case: Be Aware When Follow-up Requires Extra Steps
https://www.medscape.com/viewarticle/924898

Mar 1st, 2020 - Some communications among a patient's healthcare team may not be as direct as one would prefer, but they may still trigger a duty on the recipient to follow up. Dr P, a general pediatrician, was called to attend a vaginal delivery of a newborn wit...

Can insulin plus metformin improve pregnancy outcomes in women with type 2 diabetes?
https://www.mdedge.com/fedprac/article/214703/obstetrics/can-insulin-plus-metformin-improve-pregnancy-outcomes-women-type-2/page/0/1?channel=53

Dec 23rd, 2019 - Currently, the multisite MOMPOD trial (Medical Optimization of Management of T2DM Complicating Pregnancy) is randomizing 950 women to insulin plus 1,000 mg metformin twice daily or insulin plus placebo. The primary outcome of the trial is a compos.

Neonatal hyperbilirubinemia: An evidence-based approach
https://www.mdedge.com/familymedicine/article/193251/pediatrics/neonatal-hyperbilirubinemia-evidence-based-approach/page/0/3
MDedge Family Medicine;

Jan 28th, 2019 - The US Preventative Services Task Force, however, found insufficient evidence to recommend universal screening for infants ≥35 weeks’ gestation. 27 The main rationale for their “I” recommendation was that although screening can identify infants at.

Glyburide failed to show noninferiority in gestational diabetes
https://www.mdedge.com/familymedicine/article/164700/diabetes/glyburide-failed-show-noninferiority-gestational-diabetes
Clinical Endocrinology News; Amy Karon

May 2nd, 2018 - A randomized, multicenter trial failed to find glyburide noninferior to insulin for treatment of gestational diabetes, investigators reported. The composite rate of macrosomia, neonatal hypoglycemia, and hyperbilirubinemia was 27.

FDA Staff: Neonatal Jaundice Drug Effective, But Safety Uncertain
https://www.medpagetoday.com/pediatrics/generalpediatrics/72646

May 2nd, 2018 - WASHINGTON -- Just one dose of a drug called stannsoporfin significantly reduced bilirubin levels in newborns with severe hyperbilirubinemia, but at the potential cost of long-term neurological risk, according to an FDA briefing document prepared ...

see more →

Patient Education  1 results see all →